Search Press releases Keywords From To 17 May 2024 Transparency notification Wellington Read More 17 May 2024 Acquisition of own shares Read More 14 May 2024 New data published in the Journal of Neurology show clinically meaningful improvement of fatigue in generalized myasthenia gravis (gMG) with ZILBRYSQ[®]▼ (zilucoplan) Read More 10 May 2024 Acquisition of own shares Read More 8 May 2024 UCB presents final open-label extension FINTEPLA®▼(fenfluramine)[1] data at International Child Neurology Congress (ICNC) Annual Meeting Read More 3 May 2024 Acquisition of own shares Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
